Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceuticals
Providers
Mayo, LifePoint sue pharmas over 'pay for delay' agreements
Health systems say deals between Revlimid's owners, Celgene and Bristol-Myers Squibb, and other pharmas are anticompetitive and drive higher prices.
Dave Muoio
Oct 19, 2023 3:00pm
New Mexico, California finalize hefty opioid settlements
Jun 12, 2023 5:00pm
Nonprofits, Teva Pharma to donate mental health medications
May 9, 2023 7:00am
New coalition to advocate for equity through digital health
May 24, 2022 7:40am
Judge slims UnitedHealth's HIV drug suit against Gilead, Teva
Mar 9, 2022 12:20pm
Insurers sue pharmas, allege anticompetitive HIV drug scheme
Dec 15, 2021 11:35am